Response in chronic schizophrenia correlated with chlorpromazine, 7-OH-chlorpromazine and chlorpromazine sulfoxide levels

Author： Chetty M.   Pillay V.L.   Moodley S.V.   Miller R.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.6, Iss.2, 1996-05, pp. : 85-91

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chlorpromazine: Agranulocytosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1257, 2009-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

The use of a side effect as a qualitative indicator of plasma chlorpromazine levels

By Chetty M.   Gouws E.   Miller R.   Moodley S.  

European Neuropsychopharmacology, Vol. 9, Iss. 1, 1999-01 ,pp. : 77-82

Elsevier

Access to resources Recommend Favorite

Chlorpromazine: Corneal deposits: case report

By  

Reactions Weekly, Vol. 1, Iss. 1182, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Chlorpromazine: Neuroleptic malignant syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1409, 2012-01 ,pp. : 17-18

Adis International

Access to resources Recommend Favorite

Electrocardiogram and cardiovascular changes in thioridazine and chlorpromazine poisoning

By Strachan E.   Kelly C.   Bateman D.  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 8, 2004-10 ,pp. : 541-545

Springer Publishing Company

Access to resources Recommend Favorite